Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Barun

Barun Gorain, Toronto CA

Patent application numberDescriptionPublished
20090071295METHOD TO IMPROVE RECOVERY OF GOLD FROM DOUBLE REFRACTORY GOLD ORES - The present invention is directed to a precious metal recovery process in which carbonaceous material, such as preg robbing carbon, is floated after sulfide oxidation to separate the carbonaceous material from the precious metal.03-19-2009
20090074607PROCESS FOR RECOVERING GOLD AND SILVER FROM REFRACTORY ORES - The present invention is directed to flotation of refractory gold sulfide ores in which the ore is ground, floated, the tailings reground, and refloated to produce gold-bearing concentrates.03-19-2009
20110155651SEPARATION OF COPPER MINERALS FROM PYRITE USING AIR-METABISULFITE TREATMENT - Embodiments of the present invention are directed to flotation of sulfidic materials following aerating by an oxidizing gas and contacting by a sulfoxy reagent.06-30-2011

Barun Okram, San Diego, CA US

Patent application numberDescriptionPublished
20080287432Compounds and Compositions as Protein Kinase Inhibitors - The invention provides a novel class of compounds of formula I, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the AbI, Bcr-AbI, Aurora-A, SGK, Tie-2, Trk-B, FGFR3, c-kit, b-RAF, c-RAF, DYRK2, Fms, Fyn and PDGFRalpha and PDGFR&bgr; kinases.11-20-2008
20080300267Compounds and Compositions as Protein Kinase Inhibitors - The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the CDKs, Aurora, Jak2, Rock, CAMKII, FLT3, Tie2, TrkB, FGFR3 and KDR kinases.12-04-2008
20100048552COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHBITORS - The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, Bcr-Abl, Bcr-Abl(T315I), ALK, BLK, BMX, BRK, C-kit, c-RAF, CSK, c-SRC, EGFR, Fes, FGFR3, Flt3, Fms, Fyn, IGF-1R, IR, JAK(2), JAK(3), KDR, Lck, NLK, p70S6K, PDGFRα, Ros, SAPK2α, SGK, SIK, Syk, Tie2 and TrkB kinases.02-25-2010
20110003798COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS - The invention provides a novel class of 2,7-naphthyridin derivatives; pharmaceutical compositions comprising such compounds and methods of using such compounds to treat o prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly Syk, ZAP70, KDR, FMS, FLT*, c-Kit, RET, TrkA, TrkB, TrkC-GR-1R, Alk, c-FMS or combinations thereof.01-06-2011
20110053897COMPOUNDS AND COMPOSITIONS AS SYK KINASE INHIBITORS - Provided herein area novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated Syk kinase activity.03-03-2011

Patent applications by Barun Okram, San Diego, CA US